PRICE T ROWE ASSOCIATES INC /MD/ - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$71
-50.3%
23,195
-46.4%
0.00%
Q2 2023$143
+31.2%
43,313
+27.1%
0.00%
Q1 2023$109
-46.0%
34,089
+16.9%
0.00%
Q4 2022$202
-99.9%
29,149
+3.3%
0.00%
Q3 2022$179,000
+103.4%
28,219
+33.2%
0.00%
Q2 2022$88,000
-12.0%
21,191
+2.5%
0.00%
Q1 2022$100,000
-47.9%
20,684
+7.8%
0.00%
Q4 2021$192,000
-64.4%
19,180
-32.1%
0.00%
Q3 2021$540,000
-40.1%
28,254
+0.2%
0.00%
Q2 2021$902,000
-96.9%
28,195
-97.0%
0.00%
-100.0%
Q1 2021$28,698,000
-35.8%
951,840
-7.9%
0.00%
-40.0%
Q4 2020$44,733,000
-13.9%
1,033,820
+7.3%
0.01%
-16.7%
Q3 2020$51,976,000
-40.9%
963,412
-33.1%
0.01%
-45.5%
Q2 2020$87,937,000
+46.3%
1,440,641
+10.2%
0.01%
+10.0%
Q1 2020$60,092,000
-58.8%
1,307,476
-21.3%
0.01%
-47.4%
Q4 2019$145,741,000
+20.5%
1,660,862
+26.1%
0.02%
+11.8%
Q3 2019$120,930,000
-33.1%
1,317,037
-7.3%
0.02%
-32.0%
Q2 2019$180,721,000
-25.2%
1,420,760
-7.5%
0.02%
-30.6%
Q1 2019$241,535,000
+91.5%
1,535,210
+20.7%
0.04%
+71.4%
Q4 2018$126,137,000
-67.5%
1,271,545
-52.1%
0.02%
-63.2%
Q3 2018$387,917,000
-12.5%
2,656,969
-6.0%
0.06%
-16.2%
Q2 2018$443,398,000
-8.8%
2,825,093
-0.8%
0.07%
-11.7%
Q1 2018$486,163,000
-4.5%
2,847,222
-0.4%
0.08%
-7.2%
Q4 2017$508,965,000
+35.4%
2,857,747
+4.4%
0.08%
+29.7%
Q3 2017$375,876,000
+22.6%
2,736,626
-6.2%
0.06%
+16.4%
Q2 2017$306,585,000
+9.6%
2,918,472
-5.1%
0.06%
+5.8%
Q1 2017$279,685,000
+37.9%
3,076,847
-6.4%
0.05%
+30.0%
Q4 2016$202,880,000
-11.1%
3,288,161
-2.3%
0.04%
-13.0%
Q3 2016$228,134,000
+115.6%
3,365,797
+37.7%
0.05%
+109.1%
Q2 2016$105,817,000
+15.2%
2,444,381
+13.1%
0.02%
+10.0%
Q1 2016$91,828,000
-28.7%
2,160,663
+7.7%
0.02%
-25.9%
Q4 2015$128,781,000
-17.8%
2,005,303
+9.6%
0.03%
-22.9%
Q3 2015$156,589,000
-48.1%
1,830,380
+2.2%
0.04%
-43.5%
Q2 2015$301,591,000
+30.0%
1,791,241
-6.8%
0.06%
+29.2%
Q1 2015$232,032,000
+66.8%
1,921,268
+26.7%
0.05%
+60.0%
Q4 2014$139,134,000
+263.3%
1,516,944
+42.1%
0.03%
+275.0%
Q3 2014$38,294,000
+843.0%
1,067,271
+497.6%
0.01%
+700.0%
Q1 2014$4,061,000
-80.0%
178,585
-81.5%
0.00%
-50.0%
Q4 2013$20,292,000967,2340.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders